胃癌同期化放疗临床研究进展
被引量：2
Clinical Research Progress in Concomitant Radiochemotherapy for Gastric Cancer
摘要
全文综述胃癌新辅助和辅助同期化放疗的临床疗效。新辅助同期化放疗中紫杉类药物被广泛看好;辅助同期化放疗较早用于临床,通常是5-Fu加LV(四氢叶酸钙)联合放疗,同时其它化疗药物的使用也在探索之中。
出处
《中国肿瘤》
CAS
2008年第7期593-595,共3页
China Cancer
参考文献1
-
1Hyung-SikLee,YoungminChoi,Won-JooHur,Hyo-JinKim,Hyuk-ChanKwon,Sung-HyunKim,Jae-SeokKim,Jong-Hoon Lee,Ghap-JoongJung,Min-ChanKim.Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer:Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine[J].World Journal of Gastroenterology,2006,12(4):603-607. 被引量：10
二级参考文献20
-
1[1]Hermans J,Bonenkamp JJ,Boon MC,Bunt AM,Ohyama S,Sasako M,Van de Velde CJ.Adjuvant therapy after curative resection for gastric cancer:meta-analysis of randomized trials.J Clin Oncol 1993; 11:1441-1447
-
2[2]Earle CC,Maroun JA.Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients:revisiting a meta-analysis of randomised trials.Eur J Cancer 1999; 35:1059-64
-
3[3]Macdonald JS,Smalley SR,Benedetti J,Hundahl SA,Estes NC,Stemmermann GN,Haller DG,Ajani JA,Gunderson LL,Jessup JM,Martenson JA.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.N Engl J Med 2001; 345:725-730
-
4[4]Greene F,Page DL,Fleming ID.Stomach.In:AJCC cancer staging manual.6th ed.New York:Springer-Verlag Publisher,2002:99-106
-
5[5]Oken MM,Creech RH,Tormey DC,Horton J,Davis TE,McFadden ET,Carbone PP.Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol 1982; 5:649-655
-
6[6]Dunst J,Reese T,Sutter T,Zuhlke H,Hinke A,KollingSchlebusch K,Frings S.Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.J Clin Oncol 2002; 20:3983-3991
-
7[7]Ichikura T,Tomimatsu S,Uefuji K,Kimura M,Uchida T,Morita D,Mochizuki H.Evaluation of the New American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification.Cancer 1999; 86:553-558
-
8[8]Smalley SR,Gunderson L,Tepper J,Martenson JA Jr,Minsky B,Willett C,Rich T.Gastric surgical adjuvant radiotherapy consensus report:rationale and treatment implementation.Int J Radiat Oncol Biol Phys 2002; 52:283-293
-
9[9]Ajani JA,Welch SR,Raber MN,Fields WS,Krakoff IH.Comprehensive criteria for assessing therapy-induced toxicity.Cancer Invest 1990; 8:147-159
-
10[10]Vanhoefer U,Rougier P,Wilke H,Ducreux MP,Lacave AJ,Van Cutsem E,Planker M,Santos JG,Piedbois P,Paillot B,Bodenstein H,Schmoll HJ,Bleiberg H,Nordlinger B,Couvreur ML,Baron B,Wils JA.Final results of a randomized phase Ⅲ trial of sequential high-dose methotrexate,fluorouracil,and doxorubicin versus etoposide,leucovorin,and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer:A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.J Clin Oncol 2000; 18:2648-2657
共引文献9
-
1邓琳,金冶宁.胃癌术后辅助放化疗的进展和争议[J].外科理论与实践,2008,13(1):79-81.
-
2邱红,丁方勇,熊慧华,李瑞超.卡培他滨与氟尿嘧啶用于胃癌术后同步放射治疗和化学治疗的比较[J].医药导报,2010,29(3):306-309. 被引量：1
-
3王磊黎,梁世雄.放射治疗在胃癌治疗中的作用[J].中国癌症防治杂志,2010,2(1):74-76. 被引量：12
-
4刘芳.老年胃癌患者术后三维适形放疗同步XELOX方案化疗的临床疗效[J].中国老年学杂志,2012,32(7):1396-1398. 被引量：7
-
5李春来,吴正阳,杨卫军,陈果.适形放疗和XELOX方案联合治疗胃癌术后腹腔淋巴结转移及其机制[J].世界华人消化杂志,2013,21(31):3413-3417. 被引量：3
-
6姚俊涛,刘瑜,刘秋芳,庞宏涛,张栓宝,王蓓莉,胡玉琴.同步放化疗对不能手术局部晚期胃癌的疗效[J].现代肿瘤医学,2015,23(18):2637-2640. 被引量：4
-
7Xin Wang,Wei-Hu Wang,Shu-Lian Wang,Yong-Wen Song,Yue-Ping Liu,Yuan Tang,Ning Li,Wen-Yang Liu,Hui Fang,Ye-Xiong Li,Dong-Bing Zhao,Yihebali Chi,Lin Yang,Jing Jin.Efficacy and toxicity of capecitabine combined with intensitymodulated radiotherapy after D1/D2 lymph node dissection in patients with gastric cancer[J].World Journal of Gastrointestinal Oncology,2021,13(10):1532-1543. 被引量：1
-
8Leyla Kilic,Cetin Ordu,Ibrahim Yildiz,Fatma Sen,Serkan Keskin,Rumeysa Ciftci,Kezban Nur Pilanci.Current adjuvant treatment modalities for gastric cancer:From history to the future[J].World Journal of Gastrointestinal Oncology,2016,8(5):439-449. 被引量：9
-
9Jee Suk Chang,Woong Sub Koom,Youngin Lee,Hong In Yoon,Hyung Sik Lee.Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection?[J].World Journal of Gastroenterology,2014,20(36):12900-12907. 被引量：5
同被引文献4
-
1Ai-Wen Wu , Jia-Fu Ji.Neoadjuvant chemotherapy for locally advanced gastric cancer:With or without radiation[J].World Journal of Gastrointestinal Surgery,2012,4(2):27-31. 被引量：7
-
2孙菁,孙益红,秦新裕,曾蒙苏,王敏桦,曾昭冲.胃癌术后腹腔淋巴结转移放疗的疗效分析[J].中华放射肿瘤学杂志,2007,16(4):277-280. 被引量：10
-
3郁丰荣,曹晖,卞育海,陈治平,吴志勇.术前区域性动脉灌注化疗治疗进展期胃癌的临床研究[J].外科理论与实践,2008,13(1):44-47. 被引量：13
-
4李安振.FOLFOX4方案治疗晚期胃癌临床观察[J].肿瘤基础与临床,2010,23(3):261-262. 被引量：3
二级引证文献4
-
1石书红,张辉.老年胃癌患者术后三维适形放射治疗同步XELOX方案化学治疗的疗效[J].中国医药导刊,2013,15(12):2006-2007. 被引量：4
-
2董志强.新辅助化疗对进展期胃癌患者生活质量的影响[J].中国肿瘤临床与康复,2014,21(8):939-941. 被引量：2
-
3曾晓红,黄荣,蒋军,何瀚,邹育超,周菲菲,闵燕飞,陈默.胃癌术后腹腔淋巴结转移放疗的疗效分析[J].临床合理用药杂志,2016,9(20):115-116. 被引量：2
-
4苏益群,阮文红,陈梃,林文辉.替吉奥同步放疗在中晚期胃癌伴腹腔淋巴结转移患者中的治疗效果及安全性[J].临床医学工程,2017,24(10):1431-1432. 被引量：5
-
1郑瑾(综述),王秋明(综述),林英城(审校).临床N2期非小细胞肺癌治疗进展[J].国际肿瘤学杂志,2010,37(6):454-457.
-
2程璐,李苏宜.食管癌新辅助同期化放疗临床研究进展[J].实用肿瘤学杂志,2008,22(5):481-484. 被引量：2
-
3田云霄,张小辉.表皮生长因子受体及其与胃癌的关系研究[J].实用心脑肺血管病杂志,2012,20(5):920-922. 被引量：5
-
4赵冬梅,李伯楠.首个治疗多发性骨髓瘤的口服药物——依沙佐米[J].临床药物治疗杂志,2016,14(6):85-88. 被引量：2
-
5姚瀚.如何看胸片(上)[J].中国乡村医药,2005,12(7):73-74.
-
6孟莉,李蓉生.三氧化二砷——治疗MDS的新选择[J].中国处方药,2005,4(1):75-77. 被引量：1
-
7郭晔.多数淋巴瘤可治愈[J].特别健康,2013(7):19-19.
-
8富丹,朱敏,孙明.肿瘤放射免疫疗法的临床应用进展[J].牡丹江医学院学报,2007,28(3):62-64. 被引量：2
-
9吕大劳.走出癌症治疗的误区系列之三 肿瘤术前介入治疗和术后化疗效果截然不同[J].中国保健营养,2003(8):53-54.
-
10高燕.看好牙再放疗[J].人人健康,2009(1):33-33.
